Compile Data Set for Download or QSAR
Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 50010598
TargetBromodomain-containing protein 7(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50183448(CHEMBL3823478 | US11773085, Compound B2)
Affinity DataKd:  0.316nMAssay Description:Binding affinity to BRD7 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50183448(CHEMBL3823478 | US11773085, Compound B2)
Affinity DataKd:  0.794nMAssay Description:Binding affinity to BRD9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50147620(CHEMBL3769507)
Affinity DataKd:  2nMAssay Description:Binding affinity to BRD9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540499(CHEMBL4635496)
Affinity DataKd:  2nMAssay Description:Binding affinity to BRD9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50147620(CHEMBL3769507)
Affinity DataKi:  2nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50183449(CHEMBL3823101 | US11773085, Compound B23)
Affinity DataKd:  6.30nMAssay Description:Binding affinity to BRD9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540525(CHEMBL4642341)
Affinity DataKi:  10nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 7(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540508(CHEMBL4648548)
Affinity DataKi:  25nMAssay Description:Binding affinity to human partial length BRD7 (L125 to R254 residues) expressed in mammalian expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50266968(CHEMBL4065619 | US11773085, Compound B27)
Affinity DataKd:  32nMAssay Description:Binding affinity to BRD9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540513(CHEMBL4645418)
Affinity DataKi:  40nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540508(CHEMBL4648548)
Affinity DataKi:  40nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540522(CHEMBL4639574)
Affinity DataKi:  63nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540509(CHEMBL4644816)
Affinity DataIC50: 63nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 7(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50183449(CHEMBL3823101 | US11773085, Compound B23)
Affinity DataKd:  79nMAssay Description:Binding affinity to BRD7 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540519(CHEMBL4635895)
Affinity DataKi:  79nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540511(CHEMBL4643740)
Affinity DataKi:  79nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 7(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540499(CHEMBL4635496)
Affinity DataKd:  100nMAssay Description:Binding affinity to BRD7 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540506(CHEMBL4643455)
Affinity DataIC50: 100nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 7(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540498(CHEMBL4643109)
Affinity DataIC50: 100nMAssay Description:Binding affinity to BRD7 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540505(CHEMBL4645392)
Affinity DataIC50: 100nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540504(CHEMBL4633192)
Affinity DataIC50: 100nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540512(CHEMBL4642886)
Affinity DataKi:  100nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50157607(CHEMBL3753082 | US11773085, Compound B24)
Affinity DataKd:  100nMAssay Description:Binding affinity to BRD9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540520(CHEMBL4644517)
Affinity DataKi:  126nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540510(CHEMBL4645137)
Affinity DataKi:  158nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540523(CHEMBL4634319)
Affinity DataKi:  158nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540508(CHEMBL4648548)
Affinity DataIC50: 200nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540507(CHEMBL4646728)
Affinity DataIC50: 200nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540517(CHEMBL4642556)
Affinity DataKi:  251nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetPeregrin(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540508(CHEMBL4648548)
Affinity DataKi:  251nMAssay Description:Binding affinity to human partial length BRPF1 (E627 to G740 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540514(CHEMBL4636297)
Affinity DataKi:  251nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540521(CHEMBL4632508)
Affinity DataKi:  316nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 7(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50266968(CHEMBL4065619 | US11773085, Compound B27)
Affinity DataKd:  316nMAssay Description:Binding affinity to BRD7 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540518(CHEMBL4646338)
Affinity DataKi:  316nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540501(CHEMBL4645268)
Affinity DataIC50: 398nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 7(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50147620(CHEMBL3769507)
Affinity DataKd:  398nMAssay Description:Binding affinity to BRD7 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540516(CHEMBL4635826)
Affinity DataKi:  398nMAssay Description:Binding affinity to human partial length BRD9 (R130 to V259 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 7(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540522(CHEMBL4639574)
Affinity DataKi:  501nMAssay Description:Binding affinity to human partial length BRD7 (L125 to R254 residues) expressed in mammalian expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540503(CHEMBL4639281)
Affinity DataIC50: 794nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 7(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50157607(CHEMBL3753082 | US11773085, Compound B24)
Affinity DataKd:  1.00E+3nMAssay Description:Binding affinity to BRD7 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540500(CHEMBL4647246)
Affinity DataIC50: 1.26E+3nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540523(CHEMBL4634319)
Affinity DataKi:  1.59E+3nMAssay Description:Binding affinity to human partial length BRD4 (1) (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50234934(CHEMBL4095646)
Affinity DataIC50: 2.00E+3nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 9(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540502(CHEMBL4642945)
Affinity DataIC50: 2.51E+3nMAssay Description:Binding affinity to BRD9 (unknown origin) N-terminal bromodomain by TR-FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540513(CHEMBL4645418)
Affinity DataKi:  3.98E+3nMAssay Description:Binding affinity to human partial length BRD4 (1) (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetPeregrin(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540519(CHEMBL4635895)
Affinity DataKi:  6.31E+3nMAssay Description:Binding affinity to human partial length BRPF1 (E627 to G740 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetPeregrin(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540521(CHEMBL4632508)
Affinity DataKi:  7.94E+3nMAssay Description:Binding affinity to human partial length BRPF1 (E627 to G740 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540519(CHEMBL4635895)
Affinity DataKi:  7.94E+3nMAssay Description:Binding affinity to human partial length BRD4 (1) (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540521(CHEMBL4632508)
Affinity DataKi: <1.00E+4nMAssay Description:Binding affinity to human partial length BRD4 (1) (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50540520(CHEMBL4644517)
Affinity DataKi: <1.00E+4nMAssay Description:Binding affinity to human partial length BRD4 (1) (N44 to E168 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: